LILRB4 and acute myeloid leukemia: ApoE has been identified as an extracellular binding protein of leukocyte immunoglobulin-like receptor B4 (LILRB4), and disruption of the LILRB4/apoE interaction blocks the development of acute myeloid leukemia [38, 39].